US Autoimmune Diseases Market Landscape and Growth Prospects in Forecast Period 2015-2019 adds Autoimmune Diseases Market in the US 2015-2019 report to its store.

Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet.

Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn’s disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.

The analysts forecast autoimmune diseases market in the US to grow at a CAGR of 6.17% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the autoimmune diseases market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of autoimmune diseases.

The report, Autoimmune Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast for individual diseases as well as the overall market and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key Vendors

  • AbbVie
  • Amgen
  • Biogen
  • F. Hoffmann-La Roche
  • Janssen Pharmaceuticals

Purchase a Copy of the Report @

Other Prominent Vendors

  • AB Science
  • Acorda Therapeutics
  • aTyr Pharma
  • Baxter
  • Celgene
  • Celltrion
  • Coherus BioSciences
  • Daiichi Sankyo
  • Eli Lilly
  • GlaxoSmithKline
  • HGS
  • Hospira
  • Idera
  • Immunomedics
  • ImmuPharma
  • Invion
  • Latona Life Sciences
  • MedImmune
  • Merck
  • Novartis
  • Opexa Therapeutics
  • Principia
  • Reata Pharmaceuticals
  • Regeneron
  • Sanofi
  • Sobi
  • Takeda
  • Teva
  • UCB
  • Vaccinex
  • Vitae Pharmaceuticals

Key Market Driver

  • Unmet Medical Needs

Key Market Challenge

  • High Cost of Therapy

Key Market Trend

  • Increase in Public Awareness

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Inquire for this report @

About US: is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.